ASTROTECH Corp
ASTCNasdaqHealthcare · Laboratory Analytical Instruments · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.0M | $1.7M | $750,000 | $869,000 | $334,000 | $488,000 |
| Operating income | −$14.7M | −$13.3M | −$11.1M | −$8.6M | −$7.9M | −$8.1M |
| Net income | −$13.8M | −$11.7M | −$9.6M | −$8.3M | −$7.6M | −$8.3M |
| Total assets | $27.0M | $37.6M | $47.7M | $56.2M | $65.6M | $5.9M |
| Total liabilities | $4.9M | $2.8M | $3.0M | $3.0M | $4.4M | $5.3M |
| Equity | $22.1M | $34.8M | $44.7M | $53.2M | $61.2M | $625,000 |
| EPS (diluted) | $-8.32 | $-7.12 | $-5.95 | $-5.24 | $-0.35 | — |
| Shares out. | 1.8M | 1.7M | 1.7M | 50.6M | 49.5M | 7.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −1404.6%
- Net margin
- −1320.3%
- Return on equity
- −62.7%
- Return on assets
- −51.3%
- Return on capital (ROCE)
- −60.0%
- Liabilities / assets
- 18.1%
- Debt / equity
- 0.22×
- Book value / share
- $12.56
- Revenue growth (YoY)
- −37.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -24.48distress
- Accruals / assets
- −3.3%clean
- Beneish M-Score
- 14.22elevated
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 5 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Beneish M-Score elevated — earnings-manipulation screen flag
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Sep 30, 2014
- NT 10-Kmissed a reporting deadline ↗Oct 1, 2013
- NT 10-Kmissed a reporting deadline ↗Sep 28, 2001
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Skylark Partners I, LpPassive (13G)Dec 23, 2025
- Bml Investment Partners, L.P.Activist (13D)Oct 7, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 41,339 | 1.2 | -45.6% |
| Apr 30, 2026 | 75,943 | 1.0 | +95.2% |
| Apr 15, 2026 | 38,911 | 1.0 | -96.0% |
| Mar 31, 2026 | 960,143 | 1.0 | +3232.9% |
| Mar 13, 2026 | 28,808 | 4.4 | -2.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 13, 2026
- Results of operationsFeb 13, 2026
- Entered a material agreement · Modified shareholder rights · Shareholder voteDec 17, 2025
- Results of operationsNov 13, 2025
- Director / officer changeNov 12, 2025
- Director / officer change · Regulation FD disclosureOct 31, 2025
- Director / officer changeOct 23, 2025
- Results of operationsSep 25, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4FORM 4May 21, 2026
- 4FORM 4May 18, 2026
- 4FORM 4May 18, 2026
- 4FORM 4May 18, 2026
- 4FORM 4May 18, 2026
- 10-QFORM 10-QMay 13, 2026
- 8-KFORM 8-KMay 13, 2026
- 10-QFORM 10-QFeb 13, 2026
- 8-KFORM 8-KFeb 13, 2026
- EFFECTJan 30, 2026
- CORRESPJan 29, 2026
- UPLOADJan 29, 2026
- S-3FORM S-3Jan 28, 2026
- SCHEDULE 13GDec 23, 2025
- 8-KFORM 8-KDec 17, 2025
Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.